1) Arai H, Kobayashi K, Ichimiya Y, Kosaka K, et al. : A preliminary study of free amino acids in the postmortem temporal cortex Alzheimer-type dementia patients. Neurobio Aging, 5 : 319-321 (1984).
2) Arai H, Kosaka K, Iizuka R : Changes of biogenic amines and their metabolites in postmortem brains from patients with Alzheimer-type dementia. J Neurochem, 43 : 388-393 (1984).
3) Arai H, Moroji T, Kosaka K : Somatostatin and vasoactive intestinal polypeptide in postmortem brains from patients with Alzheimer-type dementia. Neurosci Lett, 52 : 73-78 (1984).
4) Arai H, Emson PC, Mountjoy CQ, Carassco LH, et al. : Loss of parvalbumin-immunoreactive neurones from cortex in Alzheimer-type dementia. Brain Res, 418 : 164-169 (1987).
5) Arai H, Ichimiya Y, Kosaka K, Moroji T, et al. : Neurotransmitter changes in early-and late-onset Alzheimer-type dementia. Neuropsycho Biol Psych, 16 : 883-890 (1992).
6) Atack JR, Perry EK, Bonham JR, Perry RH, et al. : Molecular forms of acetylcholinesterase in senile dementia of Alzheimer type ; Selective loss of the intermediate (10S) form. Neurosci Lett, 40 : 199-204 (1983).
7) Bowen DM, Smith CB, White P, Goodhardt MJ, et al. : Neurotransmitter-related enzymes and indices of hypoxia in senile dementia and other abiotrophies. Brain, 99 : 459-496 (1976).
8) Brane G, Gottfries CG, Blennow K, Karlsson I, et al. : Monoamine metabolites in cerebrospinal fluid and behavioral ratings in patients with early and late onset of Alzheimer dementia. Alzheimer Dis Assoc Disord, 3 : 148-156 (1989).
9) Burnstock G : Review lecture ; Neurotransmitters and trophic factors in the autonomic nervous system. J Physiol, 313 : 1-35 (1981).
10) Chan-Palay V : Galanin hyperinnervates surviving neurons of the human basal nucleus of Meynert in dementias of Alzheimer's and Parkinson's disease ; A hypothesis for the role of galanin in accentuating cholinergic dysfunction in dementia. J Comp Neurol, 273 : 543-557 (1988).
11) Coleman PD, Flood DG : Neuron numbers and dendritic extent in normal aging and Alzheimer's disease. Neurobiol Aging, 8 : 521-545 (1987).
12) Davies P, Maloney AF : Selective loss of central cholinergic neurons in Alzheimer's disease [letter]. Lancet, ii : 1403 (1976).
13) Dawbarn D, Rossor MN, Mountjoy CQ, Roth M : Decreased somatostatin immunoreactivity but not neuropeptide Y immunoreactivity in cerebral cortex in senile dementia of Alzheimer type. Neurosci Lett, 70 : 154-159 (1986).
14) Dournaud P, Cervera-Perot P, Hirsch E, Javoy-Agid F, et al. : Somatostatin messenger RNA-containing neurons in Alzheimer's desease ; An in situ hybridization study in hippocampus, parahippocampal cortex and frontal cortex. Neuroscience, 61 : 755-764 (1994).
15) Gottfries CG, Nyth AL : Effect of citalopram, a selective 5-HT reuptake blocker, in emotionally disturbed patients with dementia. Ann NY Acad Sci, 640 : 276-279 (1991).
16) Hernandez-Hernandez A, Adam A, Ravid R, Cowburn RF : Preservation of acetylcholine muscasrinic M2 receptor G-protein interactions in the neocortex of patients with Alzheimer's disease. Neurosci Lett, 186 : 57-60 (1995).
17) 小阪憲司, 新井平伊, 小林一成, 稲田雅美 : アルツハイマー型痴呆脳におけるビタミンB12の変化 ; 特にメチルB12について. Dementia, 1 : 65-68 (1987).
18) Kumashiro S, Hashimoto A, Nishikawa T : Free D-serine in post-mortem brains and spinal cords of individuals with and without neuropsychiatric diseases. Brain Res, 681 : 117-125 (1995).
19) Kunugi H, Hattori M, Ueki A, Isse K, et al. : Possible association of missence mutation (Gly [-63] Glu) of the neurotrophin-3 gene with Alzheimer's disease in Japasese. Neurosci Lett, 241 : 65-67 (1998).
20) Lowlor BA, Sunderland T, Mellow AM, Hill JL, et al. : Hyperresponsivity to the serotonin agosist m-chlorphenylpiperazine in Alzheimer's disease. Arch Gen Psychiatory, 46 : 542-549 (1989).
21) Mimori Y, Nakamura S, Yukawa M : Abnormalities of acetylcholinesterase in Alzheimer's disease with special reference to effect of acetylcholinesterase inhibitor. Behav Brain Res, 83 : 25-30 (1997).
22) Minami M, Makino Y, Arai H, Iizuka R : Adisorganized increase of galanin-like immunoreactivity in cerebral cortex of Alzheimer-type dementia brains. J Neural Transm Park Dis Dement Sect, 4 : 285-292 (1991).
23) Mountjoy CQ, Roth M, Evans NJR, Evans HH : Cortical neuronal in normal elderly controls and demented patients. Neurobiol Aging, 4 : 1-11 (1983).
24) Nordberg A, Nilsson-Hakansson L, Adam A, Hardy J, et al. : The role of the nicotinic receptors in the pathophysiology of Alzheimer's desease. Prog Brain Res, 79 : 353-362 (1989).
25) Nordberg A, Hartvig P, Linja A, Viitanen M, et al. : Nicotine receptors in the brain of patients with Alzheimer's disease ; Studies with 11C-nicotine and positron emission tomography. Acta Radiol Suppl (Stockh), 376 : 165-166 (1991).
26) Ohkura T, Isse K, Hamamoto M, Yaoi Y, et al. : Long-term estrogen replacement therapy in female patients with dementia of the Alzheimer type ; 7case reports. Dementia, 6 : 99-107 (1995).
27) Pearson RCA, Sofroniew MV, Cuello AC, Powell TPS, et al. : Persistence of cholinergic neurons in the basal nucleus in a brain with senile dementia of the Alzheimer's type demonstrated by immunohistochemical staining for choline acetyltransferase. Brain Res, 289 : 375-379 (1983).
28) Perry EK, Gibson PH, Blessed G, Perry RH, et al. : Neurotranssmiter enzyme abnormalities in senile dementia ; Choline acetyltransferase and glutarnic acid decarboxylase activities in necropsy brain tissue. J Neurol Sci, 34 : 247-265 (1977).
29) Sawada M, Hirata Y, Arai H, Iizuka R, et al. : Tyrosine hydroxylase, tryptophan hydroxylase, biopterin, and neopterin in the brains of normal controls and patients with senile dementia of Alzheimer type. J Neurothem, 48 : 760-764 (1987).
30) Shimohama S, Taniguchi T, Fujiwara M, Kameyama M : Changes in nicotinic and muscarinic cholinergic receptors in Alzheimer-type dementia. J Neurochem, 46 : 288-293 (1986).
31) Summers WK, Majovski LV, Marsh GM, Tachiki K, et al. : Oral tetrahydroaminoacridine in long-term treatment of senile dementia, Alzheimer type. N Engl J Med, 315 : 1241-1245 (1986).
33) Zubenko GS, Moossy J, Kopp U : Neurochemical correlates of major depression in primary dementia. Arch Neurol, 47 : 209-214 (1990).
34) Zubenko GS, Moossy J, Martinez AJ, Rao G, et al. : Neuropatholgic and neurochemical correlates of psychosis in primary dementia. Arch Neurol, 48 : 619-624 (1991).